These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1800400)

  • 41. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pediatric renal transplantation in France. Introduction].
    Deschênes G; Fila M
    Nephrol Ther; 2011 Dec; 7(7):582-6. PubMed ID: 22118786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current burden of end-stage kidney disease and its future trend in China.
    Zhang L; Zuo L
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):27-28. PubMed ID: 27469147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. End-stage renal disease in the Asian-Pacific region.
    Lee G
    Semin Nephrol; 2003 Jan; 23(1):107-14. PubMed ID: 12563605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. End-stage renal disease (ESRD) and its treatment in Japan.
    Tsukamoto Y
    Nephrol Dial Transplant; 2008 Aug; 23(8):2447-50. PubMed ID: 18469312
    [No Abstract]   [Full Text] [Related]  

  • 46. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different regional dynamics of end-stage renal disease in Japan by different causes.
    Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
    Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of patients referred for treatment of end-stage renal disease in a defined population.
    Hiatt RA; Friedman GD
    Am J Public Health; 1982 Aug; 72(8):829-33. PubMed ID: 7091479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Forecasting the number of patients with end-stage renal disease (Model of the system)].
    Járay J; Hídvégi M; Kaló Z; Nagy J
    Orv Hetil; 2000 Jul; 141(29):1625-9. PubMed ID: 10962899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [2004 census of the Italian nephrology and dialysis units].
    Alloatti S; Quarello F; Salomone M; Conte F; Schena FP
    G Ital Nefrol; 2007; 24(2):141-50. PubMed ID: 17458829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
    Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
    Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low birth weight and end-stage renal disease: demographic analysis by region in Japan.
    Ichikawa T; Fukuda M; Wakamatsu-Yamanaka T; Sato R; Naito T; Togawa H; Sasakawa Y; Tomonari T; Mizuno M; Miura T; Kato Y; Ono M; Shirasawa Y; Ito A; Yoshida A; Kimura G
    Clin Exp Nephrol; 2012 Aug; 16(4):596-603. PubMed ID: 22302087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Etiologies of end-stage renal disease of children in Tunisia].
    Jellouli M; Boussetta A; Abidi K; Maalej B; Naija O; Hammi Y; Zarrouk C; Mahfoudh A; Gargah T
    Nephrol Ther; 2016 Jun; 12(3):166-70. PubMed ID: 26906230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of renal replacement therapy in Veneto for 2008, 2009 and 2010.
    Nordio M; Tessitore N; Feriani M; Rossi B; Virga G; Amici G; Abaterusso C; Antonucci F;
    J Nephrol; 2013; 26 Suppl 20():S3-12. PubMed ID: 24293193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Access of Native Americans to renal transplantation in Arizona and New Mexico.
    Narva A; Stiles S; Karp S; Turak A
    Blood Purif; 1996; 14(4):293-304. PubMed ID: 8873955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New and prevalent patients with end-stage renal disease in Canada. A portrait of the year 2000.
    Desmeules M; Schaubel D; Fenton SS; Mao Y
    ASAIO J; 1995; 41(2):230-3. PubMed ID: 7640434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Geographic differences in the increasing ESRD rate have disappeared in Japan.
    Wakamatsu-Yamanaka T; Fukuda M; Sato R; Naito T; Togawa H; Tomonari T; Kato Y; Miura T; Mizuno M; Ichikawa T; Miyagi S; Shirasawa Y; Ito A; Yoshida A; Kimura G
    Clin Exp Nephrol; 2011 Oct; 15(5):708-713. PubMed ID: 21638004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. End-stage renal disease in Canada: prevalence projections to 2005.
    Schaubel DE; Morrison HI; Desmeules M; Parsons DA; Fenton SS
    CMAJ; 1999 Jun; 160(11):1557-63. PubMed ID: 10373996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Future evolution of the ESRD patient population--a perspective for the year 2000.
    Molzahn M
    Nephrol Dial Transplant; 1996; 11 Suppl 8():59-62. PubMed ID: 9044343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pattern of end stage renal disease in a tertiary care center.
    Khakurel S; Agrawal RK; Hada R
    JNMA J Nepal Med Assoc; 2009; 48(174):126-30. PubMed ID: 20387352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.